Screener
Supernus Pharmaceuticals SUPN Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's book value per share?
- Supernus Pharmaceuticals (SUPN) reported book value per share of $18.68 in Q1 2026.
- How has Supernus Pharmaceuticals's book value per share changed year-over-year?
- Supernus Pharmaceuticals's book value per share increased by 1.2% year-over-year, from $18.45 to $18.68.
- What is the long-term trend for Supernus Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's book value per share has grown at a 6.3% compound annual growth rate (CAGR), from $13.87 to $18.81.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Supernus Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude